Personalizing
Cancer Treatment for Everyone

WEBINAR

Childhood Cancer
Precision in Pediatrics: Diagnosing and Curing Childhood Cancer

Caregivers, cancer patients, and loved ones, you can watch this webinar about childhood cancer by  Dr. Jason Freedman, Dr. Gerald Wertheim and Dr. Sarah Tasian.

If you missed the webinar, you can still watch the recording here.

 

Ask our doctors your questions about cancer
Panel of Doctors Answer Your Questions About Cancer

Caregivers, patients, and loved ones joined Dr. Belisario Arango and Dr. Arturo Loaiza-Bonilla on Monday, June 19, 12 pm EDT for this very informative and interactive question and answer panel format webinar. 

Our doctors answered participants questions submitted during the webinar and ones that have been sent to Massive Bio. 

Cancer Treatment Doctor
Bringing state-of-the-art precision cancer care Bringing state-of-the-art precision cancer care to rural communities

Bringing state-of-the-art precision cancer care was aired Tuesday, March 14 at 12:00 EDT. 

Dr. Belisario Arango covered the following topics:

Why there is a higher cancer prevalence in patients in rural areas?
What are the challenges delivering cancer care to patients? 
Where is the future of cancer care going?

VIEW ALL ARTICLES

PRESS RELEASES

J.P. Morgan (JPM) Healthcare Conference Insights
J.P. Morgan (JPM) Healthcare Conference Insights from Massive Bio Co-founder and CEO, Selin Kurnaz

Hello everyone! Another JPM is over. Overall chaotic but productive for Massive Bio. There was no earthshattering learning in our core which is technology enabled precision oncology services. Maybe because we live and breathe this every day. 

Happy Valentine's Day Savings
Happy Valentine's Day Offer

We continue to support you and your loved ones by sharing new savings. 

he American Turkish Society is pleased to announce the sixth class of
Massive Bio CEO chosen for 2017 Class of Young Society Leaders

The American Turkish Society is pleased to announce the sixth class of "Young Society Leaders," a group of 25 accomplished professionals with a demonstrated record of leadership ability and commitment to serve the U.S.-Turkish community at large.

Holiday Savings New Year 2018 for Cancer Patients
2018 New Year Holiday Savings

We are starting our New Year Holiday Savings early and ending it late!
 

VIEW ALL ARTICLES

IN THE NEWS

Researchers are now developing a new method of killing cancer more effectively.
Cancer breakthrough: Novel approach can 'starve' tumors to death

Researchers are now developing a new method of killing cancer more effectively. Their strategy "starves" tumors, depriving them of the main nutrient they require to grow and spread.

 

Cervical Cancer Awareness Month
Cervical Cancer Awareness

There are over 13,000 women diagnosed with cervical cancer each year in the United States alone. In fact, even with early detection, it is estimated that there will be 13,240 new cases of invasive cervical cancer detected in 2018. In the past, cervical cancer was a leading cause of death for American women, however, it can now be prevented with the use of the Pap Smear and the HPV vaccination. Cervical cancer generally occurs in middle aged women, but it can still present itself in younger or older women who have not been screened regularly. 

A New $500 Blood Test Could Detect Cancer Before Symptoms Develop
A New $500 Blood Test Could Detect Cancer Before Symptoms Develop

An international team of researchers have developed a new test that screens for multiple types of cancer using only a blood sample.

 

A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.
Remote-controlled cancer immunotherapy system

A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

VIEW ALL ARTICLES

PUBLISHED RESEARCH

Considerations and Advancements of Precision Medicine in GI Cancers
Considerations and Advancements of Precision Medicine in GI Cancers

This activity is designed to inform physicians about the current availability and use of targeted therapies and precision medicine in gastric (GC) and other gastrointestinal (GI) cancers.

 

Oral Versus IV Oncolytics
Oral Versus IV Oncolytics

Here, we have oral drugs. How do these oral oncolytics compare to the parenteral drugs–the only drugs, really, when I was growing up in medicine–in terms of use and in terms of access?

 

Two widely used regimens for advanced-stage follicular lymphoma led to similar high rates of long-term survival, as reported in the Journal of Clinical Oncology.
Follicular Lymphoma Regimens Equivalent

Two widely used regimens for advanced-stage follicular lymphoma led to similar high rates of long-term survival, as reported in the Journal of Clinical Oncology.

 

Breast cancer control equivalent to 5 years
Extended AI Can Stop after 2 Years

Continuing adjuvant aromatase inhibitor (AI) therapy for 2 years beyond the current standard 5 years of treatment yielded the same level of recurrence prevention as continuing the treatment for an extra 5 years, according to a report at the San Antonio Breast Cancer Symposium.

 

VIEW ALL ARTICLES
Stay in Touch with Us
To speak with a dedicated cancer care specialist, contact us by one of the options listed below:
PLEASE FILL OUT FORM BELOW

X
Talk to Cancer Care Experts:
+1 (844) 627-7246
Top